ERYTHROMYCIN ESTOLATE

ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE

MeSH term MeSH ID Detail
Otitis Media D010033 12 associated lipids
Body Weight D001835 333 associated lipids
Whooping Cough D014917 6 associated lipids
Fecal Impaction D005244 1 associated lipids
Total 4

All references with ERYTHROMYCIN ESTOLATE

Download all related citations
Per page 10 20 50 100 | Total 98
Authors Title Published Journal PubMed Link
Thibault N et al. Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets. 1993 J. Hepatol. pmid:8151096
Snellman LW et al. Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. 1993 Pediatrics pmid:8502522
Adam D and Scholz H Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. 1996 Eur. J. Clin. Microbiol. Infect. Dis. pmid:8922570
Howard JE et al. Otitis media of infancy and early childhood. A double-blind study of four treatment regimens. 1976 Am. J. Dis. Child. pmid:8980
Halperin SA et al. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. 1997 Pediatrics pmid:9200361
Venkateswaran S et al. Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats. 1997 J Ethnopharmacol pmid:9292408
Koranyi KI et al. Evaluation of bacitracin ointment in the treatment of impetigo. 1976 Ohio State Med J pmid:958658
Scholz H and Noack R Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. 1998 Eur. J. Clin. Microbiol. Infect. Dis. pmid:9764549

Table of Content